Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 25, 2022

SELL
$87.2 - $114.05 $1.2 Million - $1.57 Million
-13,749 Closed
0 $0
Q4 2021

Jan 18, 2022

SELL
$119.57 - $139.07 $14 Million - $16.2 Million
-116,701 Reduced 89.46%
13,749 $1.76 Million
Q3 2021

Nov 09, 2021

BUY
$109.17 - $142.35 $75,436 - $98,363
691 Added 0.53%
130,450 $17.4 Million
Q2 2021

Aug 16, 2021

BUY
$100.34 - $115.69 $13 Million - $15 Million
129,759 New
129,759 $14 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $9.68B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track M&G Investment Management LTD Portfolio

Follow M&G Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on M&G Investment Management LTD with notifications on news.